Dr. Elizabeth Harvey received her MD from Memorial University of Newfoundland in 1982. She completed her Paediatric training at Memorial University and Dalhousie University followed by a Paediatric Nephrology Fellowship at The Hospital for Sick Children (SickKids), University of Toronto from 1986 to 1988. She joined the Division of Nephrology at SickKids in 1988.
Chronic Kidney Disease (CKD) is a life-long condition with no cure, only treatments that include conservative management with medications and diet modifications, followed by dialysis and/or kidney transplantation. The burden of care is high for children with CKD. Dr. Harvey's clinical research seeks to optimize dialysis delivery, identify and treat complications of dialysis, and carefully evaluate and appropriately implement new treatments and technologies.
Children with kidney stones are more likely to have a metabolic or inherited cause. A systematic team approach is required to investigate and treat these children: to identify inherited diseases, which, if not treated will result in end stage kidney disease or recurrent stones; to identify risk factors for stone growth; and to prescribe appropriate therapy to prevent new stone formation or growth of existing stones. Together with the Division of Urology and colleagues in the Kidney Stones clinic, Dr. Harvey and team provide combined urological and nephrological assessment to patients with complex stone disease. The urology stone database has allowed analysis of outcomes resulting in scholarly publications.
Education and experience
- 1987: FRCPC, Fellow Royal College of Physicians and Surgeons of Canada Pediatrics
- 1982: MD, Memorial University of Newfoundland, Newfoundland, Canada
- 1980: Bachelor Med Science, Memorial University of Newfoundland, Newfoundland, Canada
- 1998: Harry Bain Award for Excellence in Teaching, The Hospital for Sick Children
- 2006: Visiting Speaker, BC Children’s and Western PD Day
- 2011: Invited Speaker: 31st Annual Dialysis Conference, Phoenix Arizona, USA
- 2013: POWER Teaching Award - Post Graduate Medical Education (PGME), Department of Paediatrics, University of Toronto.
- 2014: Florence Mae McCredie Visiting ProfessorRoyal Children’s Hospital of Melbourne,Melbourne Australia
- 2016: Invited speaker - Skype Urology GrandRounds, University of California, Irvine, USA
- 2017: Invited Speaker – Skype Urology Grand Rounds, University of California, Irvine, USA
- 2017: Invited Plenary Lecture - BC Kidney Days
- 2018: Invited Speaker - Pediatric Academic Societies (PAS) Annual Meeting, Toronto, Ontario
- 2020: Invited speaker - Skype Urology Grand Rounds, University of California, Irvine, USA
- Chan EYH, Borzych-Duzalka D, Alparslan C, Harvey E, Munarriz RL, Runowski D, Vidal E, Coccia PA, Jankauskiene A, Principi I, Serdaroglu E, Szczepanska M, Tse Y, Vazquez A, Weaver DJ, Schaefer F, Warady BA, International Pediatric Peritoneal Dialysis Network. Colostomy in children on chronic peritoneal dialysis. Pediatric Nephrology 2020: Jan; 35(1): 119-126.
- Mandel-Shorer N, Tzvi-Behr S, Harvey E, Revel-Vilk S: Central venous catheter-related venous thrombosis in children with end-stage renal disease undergoing hemodialysis. Thrombosis Research 2018: Dec, 172:150-157.
- Zu’bi F, Sidler M, Harvey E, Lopes RI, Hojjat A, Naoum N, Pokarowski M, Lorenzo AJ, Farhat WA, Papanikolaou F, Dos Santos J: Stone growth patterns and risk for surgery among children presenting with hypercalciuria, hypocitraturia and cystinuria as underlying metabolic causes of urolithiasis. J Pediatr Urol 2017: Aug 13(4): 357.
- Chanchlani R, Ackerman S, Piva E, Harvey E: Intraperitoneal Calcitriol for treatment of severe hyperparathyroidism in children with chronic kidney disease: A therapy forgotten. Peritoneal Dialysis International 2016: Nov-Dec;36(6): 688-690.
- Rousso S, Banh TM, Ackerman S, Piva E, Licht C, Harvey EA: Impact of fill volume on ultrafiltration with icodextrin in children on chronic peritoneal dialysis. Pediatric Nephrology, 2016: Oct 31(10): 1673-9